The Application of Ultrasmall Gold Nanoparticles (2 nm) Functionalized with Doxorubicin in Three-Dimensional Normal and Glioblastoma Organoid Models of the Blood–Brain Barrier
Molecules · 24.05.2024 · 29 (11) · 2469
DOI: 10.3390/molecules29112469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 24.05.2024. Verfasst von Kathrin Kostka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Inorganic Chemistry and Center for Nanointegration Duisburg-Essen (CENIDE), University of Duisburg-Essen, Universitaetsstr. 5-7, 45141 Essen, Germany. Hauptthemen laut MEDLINE: Doxorubicin, Glioblastoma, Metal Nanoparticles, Gold. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Deutscher Akademischer Austauschdienst, Bundesministerium für Bildung und Forschung (BMB).
Abstract (Originalsprache)
Among brain tumors, glioblastoma (GBM) is very challenging to treat as chemotherapeutic drugs can only penetrate the brain to a limited extent due to the blood–brain barrier (BBB). Nanoparticles can be an attractive solution for the treatment of GBM as they can transport drugs across the BBB into the tumor. In this study, normal and GBM organoids comprising six brain cell types were developed and applied to study the uptake, BBB penetration, distribution, and efficacy of fluorescent, ultrasmall gold nanoparticles (AuTio-Dox-AF647s) conjugated with doxorubicin (Dox) and AlexaFluor-647-cadaverine (AF647) by confocal laser scanning microscopy (CLSM), using a mixture of dissolved doxorubicin and fluorescent AF647 molecules as a control. It was shown that the nanoparticles could easily penetrate the BBB and were found in normal and GBM organoids, while the dissolved Dox and AF647 molecules alone were unable to penetrate the BBB. Flow cytometry showed a reduction in glioblastoma cells after treatment with AuTio-Dox nanoparticles, as well as a higher uptake of these nanoparticles by GBM cells in the GBM model compared to astrocytes in the normal cell organoids. In summary, our results show that ultrasmall gold nanoparticles can serve as suitable carriers for the delivery of drugs into organoids to study BBB function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inorganic Chemistry and Center for Nanointegration Duisburg-Essen (CENIDE), University of Duisburg-Essen, Universitaetsstr. 5-7, 45141 Essen, Germany.
- Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA.
ORCID-Profile: Kathrin Kostka, Daniel Porada, Oleg Prymak, Matthias Epple, Anthony J Atala
Förderung
- NINDS NIH HHS
- Deutscher Akademischer Austauschdienst
- Bundesministerium für Bildung und Forschung (BMB)
Zitieren
APA
Kostka, K., Sokolova, V., El-Taibany, A., Kruse, B., Porada, D., Wolff, N., Prymak, O., Seeds, M. C., Epple, M., & Atala, A. J. (2024). The Application of Ultrasmall Gold Nanoparticles (2 nm) Functionalized with Doxorubicin in Three-Dimensional Normal and Glioblastoma Organoid Models of the Blood–Brain Barrier. Molecules, 29(11), 2469. https://doi.org/10.3390/molecules29112469
Vancouver
Kostka K, Sokolova V, El-Taibany A, Kruse B, Porada D, Wolff N, et al. The Application of Ultrasmall Gold Nanoparticles (2 nm) Functionalized with Doxorubicin in Three-Dimensional Normal and Glioblastoma Organoid Models of the Blood–Brain Barrier. Molecules. 2024;29(11):2469. doi:10.3390/molecules29112469
BibTeX
@article{Kostka2024,
author = {Kostka, Kathrin and Sokolova, Viktoriya and El-Taibany, Aya and Kruse, Benedikt and Porada, Daniel and Wolff, Natalie and Prymak, Oleg and Seeds, Michael C and Epple, Matthias and Atala, Anthony J},
title = {The Application of Ultrasmall Gold Nanoparticles (2 nm) Functionalized with Doxorubicin in Three-Dimensional Normal and Glioblastoma Organoid Models of the Blood–Brain Barrier},
journal = {Molecules},
year = {2024},
volume = {29},
number = {11},
pages = {2469},
doi = {10.3390/molecules29112469}
}
EUVIMED